Achieve Life Sciences (ACHV) vs ImmuCell (ICCC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Achieve Life Sciences (ACHV) has outperformed ImmuCell (ICCC) over the past year, gaining 118.1% versus a gain of 50.2%. Over five years, ICCC leads with a +4.4% price change compared with -10.1% for ACHV. Achieve Life Sciences is the larger company by market cap ($746.5 million vs $88.0 million), about 8.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACHV | ICCC |
|---|---|---|
| Share price | $7.24 | $9.69 |
| Market cap | $746.46M | $88.01M |
| 1-day change | +2.99% | -2.81% |
| YTD return | +45.67% | +57.56% |
| 1-year return | +118.07% | +50.23% |
| 5-year return | -10.06% | +4.42% |
| P/E ratio (TTM) | — | 138.43 |
| EPS (TTM) | $-1.69 | $0.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.64 | $12.10 |
| 52-week low | $2.62 | $4.52 |
| Distance from 52-week high | -16.20% | -19.92% |
| Average volume | 1.45M | 23.16K |
| Shares outstanding | 103.10M | 9.08M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Achieve Life Sciences is about 8.5 times larger than ImmuCell by market value ($746.46M vs $88.01M).
- ACHV has outperformed ICCC by 67.8 percentage points over the past year.
ACHV vs ICCC FAQ
Which is bigger, Achieve Life Sciences or ImmuCell?
Achieve Life Sciences (ACHV) is larger, with a market capitalization of $746.46M compared with $88.01M for ImmuCell (ICCC).
Which stock has performed better over the past year, ACHV or ICCC?
ACHV returned +118.07% over the past 12 months, compared with +50.23% for ICCC (price return, excluding dividends). Past performance does not predict future results.
Are Achieve Life Sciences and ImmuCell in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.